Publications in collaboration with researchers from Centre Georges François Leclerc (1)

2014

  1. Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: A European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup study

    Journal of Clinical Oncology, Vol. 32, Núm. 4, pp. 320-326